Logo image of AMCX

AMC NETWORKS INC-A (AMCX) Stock Fundamental Analysis

NASDAQ:AMCX - Nasdaq - US00164V1035 - Common Stock - Currency: USD

6.15  -0.08 (-1.28%)

After market: 6.15 0 (0%)

Fundamental Rating

4

Taking everything into account, AMCX scores 4 out of 10 in our fundamental rating. AMCX was compared to 98 industry peers in the Media industry. AMCX has only an average score on both its financial health and profitability. AMCX is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AMCX was profitable.
In the past year AMCX had a positive cash flow from operations.
Of the past 5 years AMCX 4 years were profitable.
Each year in the past 5 years AMCX had a positive operating cash flow.
AMCX Yearly Net Income VS EBIT VS OCF VS FCFAMCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.87%, AMCX is doing worse than 63.92% of the companies in the same industry.
Looking at the Return On Equity, with a value of -28.61%, AMCX is doing worse than 62.89% of the companies in the same industry.
AMCX's Return On Invested Capital of 7.00% is fine compared to the rest of the industry. AMCX outperforms 74.23% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMCX is in line with the industry average of 7.58%.
Industry RankSector Rank
ROA -5.87%
ROE -28.61%
ROIC 7%
ROA(3y)-0.24%
ROA(5y)1.64%
ROE(3y)-1.66%
ROE(5y)12.68%
ROIC(3y)8.36%
ROIC(5y)9.1%
AMCX Yearly ROA, ROE, ROICAMCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

AMCX's Operating Margin of 15.47% is fine compared to the rest of the industry. AMCX outperforms 79.38% of its industry peers.
In the last couple of years the Operating Margin of AMCX has declined.
With a decent Gross Margin value of 52.59%, AMCX is doing good in the industry, outperforming 62.89% of the companies in the same industry.
AMCX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.47%
PM (TTM) N/A
GM 52.59%
OM growth 3Y-8.13%
OM growth 5Y-8.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.38%
GM growth 5Y0.47%
AMCX Yearly Profit, Operating, Gross MarginsAMCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

AMCX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, AMCX has more shares outstanding
AMCX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMCX has a worse debt to assets ratio.
AMCX Yearly Shares OutstandingAMCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AMCX Yearly Total Debt VS Total AssetsAMCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 1.82 indicates that AMCX is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMCX has a better Altman-Z score (1.82) than 64.95% of its industry peers.
The Debt to FCF ratio of AMCX is 8.35, which is on the high side as it means it would take AMCX, 8.35 years of fcf income to pay off all of its debts.
AMCX has a Debt to FCF ratio of 8.35. This is in the better half of the industry: AMCX outperforms 64.95% of its industry peers.
AMCX has a Debt/Equity ratio of 2.53. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.53, AMCX is not doing good in the industry: 76.29% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF 8.35
Altman-Z 1.82
ROIC/WACC1.4
WACC5%
AMCX Yearly LT Debt VS Equity VS FCFAMCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

AMCX has a Current Ratio of 2.26. This indicates that AMCX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AMCX (2.26) is better than 73.20% of its industry peers.
A Quick Ratio of 2.26 indicates that AMCX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.26, AMCX is in the better half of the industry, outperforming 73.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 2.26
AMCX Yearly Current Assets VS Current LiabilitesAMCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1

3. Growth

3.1 Past

The earnings per share for AMCX have decreased strongly by -42.43% in the last year.
AMCX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.67% yearly.
Looking at the last year, AMCX shows a decrease in Revenue. The Revenue has decreased by -8.14% in the last year.
The Revenue has been decreasing by -4.58% on average over the past years.
EPS 1Y (TTM)-42.43%
EPS 3Y-25.75%
EPS 5Y-15.67%
EPS Q2Q%-55.17%
Revenue 1Y (TTM)-8.14%
Revenue growth 3Y-7.68%
Revenue growth 5Y-4.58%
Sales Q2Q%-6.91%

3.2 Future

AMCX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.59% yearly.
AMCX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.27% yearly.
EPS Next Y-35.66%
EPS Next 2Y-21.42%
EPS Next 3Y-16.17%
EPS Next 5Y2.59%
Revenue Next Year-6.28%
Revenue Next 2Y-4.13%
Revenue Next 3Y-3.24%
Revenue Next 5Y-4.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AMCX Yearly Revenue VS EstimatesAMCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
AMCX Yearly EPS VS EstimatesAMCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 1.86, the valuation of AMCX can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of AMCX indicates a rather cheap valuation: AMCX is cheaper than 98.97% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of AMCX to the average of the S&P500 Index (27.54), we can say AMCX is valued rather cheaply.
The Price/Forward Earnings ratio is 2.52, which indicates a rather cheap valuation of AMCX.
97.94% of the companies in the same industry are more expensive than AMCX, based on the Price/Forward Earnings ratio.
AMCX is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 1.86
Fwd PE 2.52
AMCX Price Earnings VS Forward Price EarningsAMCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMCX indicates a rather cheap valuation: AMCX is cheaper than 93.81% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, AMCX is valued cheaply inside the industry as 97.94% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.98
EV/EBITDA 3.8
AMCX Per share dataAMCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

A cheap valuation may be justified as AMCX's earnings are expected to decrease with -16.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.42%
EPS Next 3Y-16.17%

0

5. Dividend

5.1 Amount

No dividends for AMCX!.
Industry RankSector Rank
Dividend Yield N/A

AMC NETWORKS INC-A

NASDAQ:AMCX (7/18/2025, 8:00:01 PM)

After market: 6.15 0 (0%)

6.15

-0.08 (-1.28%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-08 2025-08-08/bmo
Inst Owners106.41%
Inst Owner Change0.1%
Ins Owners2.72%
Ins Owner Change1.05%
Market Cap276.32M
Analysts46.67
Price Target6.02 (-2.11%)
Short Float %16.32%
Short Ratio9.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-35.5%
Min EPS beat(2)-36.66%
Max EPS beat(2)-34.35%
EPS beat(4)1
Avg EPS beat(4)-12.01%
Min EPS beat(4)-36.66%
Max EPS beat(4)42.91%
EPS beat(8)3
Avg EPS beat(8)-4.4%
EPS beat(12)6
Avg EPS beat(12)9.27%
EPS beat(16)9
Avg EPS beat(16)28.29%
Revenue beat(2)0
Avg Revenue beat(2)-3.99%
Min Revenue beat(2)-4.4%
Max Revenue beat(2)-3.59%
Revenue beat(4)2
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)2.05%
Revenue beat(8)2
Avg Revenue beat(8)-2.66%
Revenue beat(12)3
Avg Revenue beat(12)-3.51%
Revenue beat(16)6
Avg Revenue beat(16)-1.58%
PT rev (1m)0%
PT rev (3m)-28.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.15%
Valuation
Industry RankSector Rank
PE 1.86
Fwd PE 2.52
P/S 0.12
P/FCF 0.98
P/OCF 0.83
P/B 0.31
P/tB N/A
EV/EBITDA 3.8
EPS(TTM)3.31
EY53.82%
EPS(NY)2.44
Fwd EY39.66%
FCF(TTM)6.25
FCFY101.65%
OCF(TTM)7.42
OCFY120.71%
SpS52.97
BVpS19.78
TBVpS-27.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.87%
ROE -28.61%
ROCE 10.29%
ROIC 7%
ROICexc 9.25%
ROICexgc 42.29%
OM 15.47%
PM (TTM) N/A
GM 52.59%
FCFM 11.8%
ROA(3y)-0.24%
ROA(5y)1.64%
ROE(3y)-1.66%
ROE(5y)12.68%
ROIC(3y)8.36%
ROIC(5y)9.1%
ROICexc(3y)10.3%
ROICexc(5y)11.26%
ROICexgc(3y)45.57%
ROICexgc(5y)45.25%
ROCE(3y)12.28%
ROCE(5y)13.37%
ROICexcg growth 3Y-5.75%
ROICexcg growth 5Y4.36%
ROICexc growth 3Y-6.93%
ROICexc growth 5Y-6.93%
OM growth 3Y-8.13%
OM growth 5Y-8.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.38%
GM growth 5Y0.47%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF 8.35
Debt/EBITDA 4.87
Cap/Depr 56.57%
Cap/Sales 2.21%
Interest Coverage 2.37
Cash Conversion 72.31%
Profit Quality N/A
Current Ratio 2.26
Quick Ratio 2.26
Altman-Z 1.82
F-Score6
WACC5%
ROIC/WACC1.4
Cap/Depr(3y)39.93%
Cap/Depr(5y)41.94%
Cap/Sales(3y)1.53%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.43%
EPS 3Y-25.75%
EPS 5Y-15.67%
EPS Q2Q%-55.17%
EPS Next Y-35.66%
EPS Next 2Y-21.42%
EPS Next 3Y-16.17%
EPS Next 5Y2.59%
Revenue 1Y (TTM)-8.14%
Revenue growth 3Y-7.68%
Revenue growth 5Y-4.58%
Sales Q2Q%-6.91%
Revenue Next Year-6.28%
Revenue Next 2Y-4.13%
Revenue Next 3Y-3.24%
Revenue Next 5Y-4.27%
EBIT growth 1Y-17.06%
EBIT growth 3Y-15.19%
EBIT growth 5Y-12.77%
EBIT Next Year-21.19%
EBIT Next 3Y-13.82%
EBIT Next 5Y-9.08%
FCF growth 1Y882.08%
FCF growth 3Y48.56%
FCF growth 5Y-3.34%
OCF growth 1Y357.55%
OCF growth 3Y37.82%
OCF growth 5Y-4.93%